These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3265501)

  • 1. Effects of tumour necrosis factor and alpha interferon on chronic B cell malignancies.
    Bianchi AC; Heslop HE; Drexler HG; Cordingley FT; Turner M; De Mel WC; Hoffbrand AV; Brenner MK
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):317-9. PubMed ID: 3265501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
    Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
    Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-2 enhances the production of tumor necrosis factor-alpha in activated B-type chronic lymphocytic leukemia (B-CLL) cells.
    Larsson LG; Carlsson M; Schena M; Lantz M; Caligaris-Cappio F; Nilsson K
    Leukemia; 1993 Feb; 7(2):226-34. PubMed ID: 8381194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
    Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ
    J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
    de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
    Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-alpha in vivo enhances tumor necrosis factor receptor levels on hairy cells.
    Billard C; Sigaux F; Wietzerbin J
    J Immunol; 1990 Sep; 145(6):1713-8. PubMed ID: 2167909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression.
    Wu S; Boyer CM; Whitaker RS; Berchuck A; Wiener JR; Weinberg JB; Bast RC
    Cancer Res; 1993 Apr; 53(8):1939-44. PubMed ID: 8385577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-alpha facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L.
    Ranheim EA; Kipps TJ
    Cell Immunol; 1995 Apr; 161(2):226-35. PubMed ID: 7535196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis.
    Wanidworanun C; Strober W
    J Immunol; 1993 Dec; 151(12):6853-61. PubMed ID: 8258695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
    J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro.
    Djurdjevic P; Zelen I; Ristic P; Baskic D; Popovic S; Arsenijevic N
    Arch Med Res; 2009 Jul; 40(5):357-63. PubMed ID: 19766898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of interferon-alpha on the expression of cellular oncogenes in primary chronic lymphocytic leukemia cells.
    Einhorn S; Showe L; Ostlund L; Juliusson G; Robèrt KH; Gahrton G; Croce C
    Oncogene Res; 1988; 3(1):39-49. PubMed ID: 3060797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor modulates CD 20 expression on cells from chronic lymphocytic leukemia: a new role for TNF alpha?
    Sivaraman S; Deshpande CG; Ranganathan R; Huang X; Jajeh A; O'Brien T; Huang RW; Gregory SA; Venugopal P; Preisler HD
    Microsc Res Tech; 2000 Aug; 50(3):251-7. PubMed ID: 10891891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tumor necrosis factor alpha in hyperthermia-induced apoptosis of human leukemia cells.
    Katschinski DM; Robins HI; Schad M; Frede S; Fandrey J
    Cancer Res; 1999 Jul; 59(14):3404-10. PubMed ID: 10416602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of tumor necrosis factor-alpha by normal and malignant B lymphocytes in response to interferon-alpha, interferon-gamma and interleukin-4.
    Jansen JH; Wientjens GJ; Willemze R; Kluin-Nelemans JC
    Leukemia; 1992 Feb; 6(2):116-9. PubMed ID: 1552742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization.
    Boldrini L; Calcinai A; Samaritani E; Pistolesi F; Mussi A; Lucchi M; Angeletti CA; Basolo F; Fontanini G
    Br J Cancer; 2000 Aug; 83(4):480-6. PubMed ID: 10945495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.
    Poggi A; Venturino C; Catellani S; Clavio M; Miglino M; Gobbi M; Steinle A; Ghia P; Stella S; Caligaris-Cappio F; Zocchi MR
    Cancer Res; 2004 Dec; 64(24):9172-9. PubMed ID: 15604289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of intracellular IL-2, TNF-alpha, and IFN-gamma by T cells in B-CLL.
    Gallego A; Vargas JA; Castejón R; Citores MJ; Romero Y; Millán I; Durántez A
    Cytometry B Clin Cytom; 2003 Nov; 56(1):23-9. PubMed ID: 14582134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells.
    Secchiero P; Tiribelli M; Barbarotto E; Celeghini C; Michelutti A; Masolini P; Fanin R; Zauli G
    J Cell Physiol; 2005 Nov; 205(2):246-52. PubMed ID: 15887227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia.
    Haiat S; Billard C; Quiney C; Ajchenbaum-Cymbalista F; Kolb JP
    Immunology; 2006 Jul; 118(3):281-92. PubMed ID: 16827889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.